Dr. Shawn Hauser, Cannabis Legislative and Policy Update

February 2023

Ms. Shawn Hauser is a partner at Vicente Sederberg and co-chair of the firm’s Hemp and Cannabinoids Department as well as a leader in the firm’s psychedelics and emerging therapies practice. Shawn helps cannabis, hemp, and psychedelics businesses navigate the intersections between state and federal law including cannabis and psychedelics laws and food and drug laws as they evolve. Her practice includes regulatory compliance, licensing, general business representation, investment, policy reform and strategic guidance to best position businesses for success at the at state, national, and international levels.

Shawn has presented cannabis law and policy to many local, federal, and international agencies, including the Food and Drug Administration and UK Parliament. She is on the Board of Directors of the International Cannabis Bar Association, and was on the steering committee for the American Hemp Campaign, a project of Vote Hemp which was instrumental in legalizing hemp in Texas in 2019. In 2023, Shawn was recognized by her peers in the “Best Lawyers” list for her work in cannabis law.

Since directing Sensible Colorado’s local government implementation team following the passage of Amendment 64, Shawn remains active in policy work with local and state governments in Colorado and Texas and is passionate in supporting the development and implementation of cannabis, hemp, and psychedelics regulations that advance the cannabis industry in a dynamic and responsible manner. After attending law school at the University of Denver, Shawn was an associate attorney at McAllister, Darnell & Gottlieb PC, one of the first marijuana-focused law firms in Colorado.

Previous Webinars

Michael Petersen

Apr 15, 2026 11:00 AM Mountain Time

Trait Modifications in Cannabis Through Engineering and Editing

Michael Petersen has over 40 years of experience as a researcher and mentor in the plant biotech space. He worked for 10 years at Agracetus, a small startup in Wisconsin and then 20 years as a Senior Fellow with Monsanto. Mike stayed […]

Read More »

Francesca Filbey, PhD

Apr 9, 2026 01:00 PM Mountain Time

Understanding Cannabis Use Disorder Through Neuroimaging and Behavior

Francesca Filbey is a Professor and Director of the NeuroImaging of Reward Dynamics Laboratory at the Center for BrainHealth, School of Behavioral and Brain Sciences at The University of Texas at Dallas, and an Adjunct Associate Professor at the University of Texas […]

Read More »

Travis Higginbotham

March 25 at 11:00 AM (MDT)

Turning Science into Cash Flow. Crop production performance and ROI analysis driven by crop science.25

Travis Higginbitham is the Founder & CEO of Due Diligence Horticulture (DDH). He is a horticultural and operations executive with deep experience leading controlled-environment agriculture, cannabis, and ornamental production businesses through innovation, growth, transition, and turnaround. Mr. […]

Read More »

Dr. Yan Wang

12 March, 1:00 PM MST

Real-time and long-term effects of medical marijuana on older adults with chronic pain: Early findings from a prospective cohort study.

 

Yan Wang is an Associate Professor of Epidemiology at the University of Florida (UF). Her research interests focus on leveraging advanced technologies and methods (e.g., wearable sensors, ecological momentary assessment/EMA) to improve […]

Read More »

Igor Grant, M.D. and Thomas Marcotte, Ph.D.

Thursday, February 12th at 1:00 PM MST

The UC San Diego Center for Medicinal Cannabis Research: Some Findings

Igor Grant, MD is Distinguished Professor, and Director of the Center for Medicinal Cannabis Research (CMCR) at the University of California San Diego (UCSD). Established in 2000, the CMCR has been at the forefront of advancing science and policy […]

Read More »

Almut Winterstein, PhD.

Jan 8, 2026 01:00 PM Mountain Time

Clinical research priorities gleaned real-world use patterns: the MEdical Marijuana Outcomes Research repositorY (MEMORY)

Almut Winterstein is Distinguished Professor and the Dr. Robert and Barbara Crisafi Chair for Medication Safety in the Department of Pharmaceutical Outcomes and Policy and in the Department of Epidemiology, and the founding Director of the […]

Read More »